FOLH1 and posterior cortical atrophy: Over the last year’s positron emission tomography (PET) with a prostate specific membrane antigen (PSMA) tracer got higher priority focusing primarily biochemical PCA recurrence and/or M and N staging in high-risk PCA [7–9].